Annual CFF
$40.75 M
+$66.68 M+257.14%
December 31, 2023
Summary
- As of February 7, 2025, CGEM annual cash flow from financing activities is $40.75 million, with the most recent change of +$66.68 million (+257.14%) on December 31, 2023.
- During the last 3 years, CGEM annual CFF has fallen by -$99.39 million (-70.92%).
- CGEM annual CFF is now -84.84% below its all-time high of $268.78 million, reached on December 31, 2021.
Performance
CGEM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.32 M
-$260.87 M-99.49%
September 30, 2024
Summary
- As of February 7, 2025, CGEM quarterly cash flow from financing activities is $1.32 million, with the most recent change of -$260.87 million (-99.49%) on September 30, 2024.
- Over the past year, CGEM quarterly CFF has dropped by -$260.87 million (-99.49%).
- CGEM quarterly CFF is now -99.50% below its all-time high of $264.58 million, reached on March 31, 2021.
Performance
CGEM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$264.85 M
+$1.21 M+0.46%
September 30, 2024
Summary
- As of February 7, 2025, CGEM TTM cash flow from financing activities is $264.85 million, with the most recent change of +$1.21 million (+0.46%) on September 30, 2024.
- Over the past year, CGEM TTM CFF has increased by +$1.21 million (+0.46%).
- CGEM TTM CFF is now -32.37% below its all-time high of $391.61 million, reached on June 30, 2021.
Performance
CGEM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CGEM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +257.1% | -99.5% | +0.5% |
| 3 y3 years | -70.9% | +128.8% | -32.3% |
| 5 y5 years | +10000.0% | - | - |
CGEM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -84.8% | +257.1% | -99.5% | +104.0% | -1.5% | +1056.7% |
| 5 y | 5-year | -84.8% | +257.1% | -99.5% | +104.0% | -32.4% | +1056.7% |
| alltime | all time | -84.8% | +257.1% | -99.5% | +104.0% | -32.4% | +1056.7% |
Cullinan Oncology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.32 M(-99.5%) | $264.85 M(+0.5%) |
| Jun 2024 | - | $262.20 M(>+9900.0%) | $263.64 M(+558.3%) |
| Mar 2024 | - | $1.08 M(+337.5%) | $40.05 M(-1.7%) |
| Dec 2023 | $40.75 M(-257.1%) | $248.00 K(+121.4%) | $40.75 M(+436.8%) |
| Sep 2023 | - | $112.00 K(-99.7%) | $7.59 M(-14.7%) |
| Jun 2023 | - | $38.60 M(+2057.7%) | $8.90 M(-132.2%) |
| Mar 2023 | - | $1.79 M(-105.4%) | -$27.68 M(+6.8%) |
| Dec 2022 | -$25.93 M(-109.6%) | -$32.91 M(-2409.6%) | -$25.93 M(-367.9%) |
| Sep 2022 | - | $1.43 M(-29.2%) | $9.68 M(+9.6%) |
| Jun 2022 | - | $2.01 M(-43.2%) | $8.84 M(+14.1%) |
| Mar 2022 | - | $3.54 M(+31.1%) | $7.75 M(-97.1%) |
| Dec 2021 | $268.78 M(+91.8%) | $2.70 M(+366.7%) | $268.78 M(-31.3%) |
| Sep 2021 | - | $579.00 K(-37.3%) | $390.98 M(-0.2%) |
| Jun 2021 | - | $923.00 K(-99.7%) | $391.61 M(+0.2%) |
| Mar 2021 | - | $264.58 M(+111.8%) | $390.68 M(+178.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $140.14 M(+63.5%) | $124.90 M(>+9900.0%) | $140.14 M(+819.4%) |
| Sep 2020 | - | $1.21 M(>+9900.0%) | $15.24 M(+8.6%) |
| Jun 2020 | - | $0.00(-100.0%) | $14.04 M(0.0%) |
| Mar 2020 | - | $14.04 M | $14.04 M |
| Dec 2019 | $85.72 M(<-9900.0%) | - | - |
| Dec 2018 | -$29.00 K(-117.0%) | - | - |
| Dec 2016 | $170.30 K(+932.1%) | - | - |
| Dec 2015 | $16.50 K(-80.4%) | - | - |
| Dec 2014 | $84.30 K(-88.0%) | - | - |
| Dec 2013 | $703.00 K(+386.8%) | - | - |
| Dec 2012 | $144.40 K(-12.8%) | - | - |
| Dec 2011 | $165.60 K(-81.6%) | - | - |
| Dec 2010 | $898.00 K(+206.9%) | - | - |
| Dec 2009 | $292.60 K(+902.1%) | - | - |
| Dec 2008 | $29.20 K(+412.3%) | - | - |
| Dec 2007 | $5700.00 | - | - |
FAQ
- What is Cullinan Oncology annual cash flow from financing activities?
- What is the all time high annual CFF for Cullinan Oncology?
- What is Cullinan Oncology annual CFF year-on-year change?
- What is Cullinan Oncology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cullinan Oncology?
- What is Cullinan Oncology quarterly CFF year-on-year change?
- What is Cullinan Oncology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cullinan Oncology?
- What is Cullinan Oncology TTM CFF year-on-year change?
What is Cullinan Oncology annual cash flow from financing activities?
The current annual CFF of CGEM is $40.75 M
What is the all time high annual CFF for Cullinan Oncology?
Cullinan Oncology all-time high annual cash flow from financing activities is $268.78 M
What is Cullinan Oncology annual CFF year-on-year change?
Over the past year, CGEM annual cash flow from financing activities has changed by +$66.68 M (+257.14%)
What is Cullinan Oncology quarterly cash flow from financing activities?
The current quarterly CFF of CGEM is $1.32 M
What is the all time high quarterly CFF for Cullinan Oncology?
Cullinan Oncology all-time high quarterly cash flow from financing activities is $264.58 M
What is Cullinan Oncology quarterly CFF year-on-year change?
Over the past year, CGEM quarterly cash flow from financing activities has changed by -$260.87 M (-99.49%)
What is Cullinan Oncology TTM cash flow from financing activities?
The current TTM CFF of CGEM is $264.85 M
What is the all time high TTM CFF for Cullinan Oncology?
Cullinan Oncology all-time high TTM cash flow from financing activities is $391.61 M
What is Cullinan Oncology TTM CFF year-on-year change?
Over the past year, CGEM TTM cash flow from financing activities has changed by +$1.21 M (+0.46%)